Skip to main content
Log in

Escitalopram eases anxiety at low cost in GAD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Iskedjian M, Walker JH, Bereza BG, Le Melledo J-M, Einarson TR.Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada. Current Medical Research and Opinion 24: 1539-1548, No. 5, 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Escitalopram eases anxiety at low cost in GAD. Pharmacoecon. Outcomes News 554, 7 (2008). https://doi.org/10.2165/00151234-200805540-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805540-00016

Keywords

Navigation